{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:44:22Z","timestamp":1754599462472,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1245\/s10434-022-12169-w","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:03:35Z","timestamp":1657127015000},"page":"7713-7714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer?"],"prefix":"10.1245","volume":"29","author":[{"given":"Mara A.","family":"Piltin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3228","authenticated-orcid":false,"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"1","key":"12169_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"12169_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","volume":"19","author":"WJ Gradishar","year":"2021","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines insights: breast cancer. J Natl Compr Canc Netw. 2021;19(5):484\u201393.","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"12169_CR3","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. The COMET (comparison of operative versus monitoring and endocrine therapy) trial: a phase iii randomised controlled clinical trial for low-risk ductal carcinoma in Situ (DCIS). BMJ Open. 2019;9(3):e026797.","journal-title":"BMJ Open."},{"key":"12169_CR4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12099-7","author":"M Piltin","year":"2022","unstructured":"Piltin M, Hoskin T, Day C, Boughey JC. Overuse of axillary surgery in patients with ductal carcinoma in situ\u2013opportunity for de-escalation. Ann Surg Oncol. 2022. https:\/\/doi.org\/10.1245\/s10434-022-12099-7.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"12169_CR5","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","volume":"24","author":"JW Jakub","year":"2017","unstructured":"Jakub JW, Murphy BL, Gonzalez AB, et al. A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease. Ann Surg Oncol. 2017;24(10):2915\u201324.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"12169_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/bjs.11110","volume":"106","author":"A Karakatsanis","year":"2019","unstructured":"Karakatsanis A, Hersi A-F, Pistiolis L, et al. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (sentinot study). Br J Surg. 2019;106(6):720\u20138.","journal-title":"Br J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12169-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T22:11:10Z","timestamp":1665439870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12169-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12169"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12169-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mara A. Piltin and Judy C. Boughey have no conflicts of interest or sources of funding to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}